Finance

Lists
Why is 530317 up 2,77%?
Dive Deeper
530317:BOM
Godavari Drugs Ltd
133,40 INR
+2,77%
(+3,60) 1D
16 ოქტ, 15:50:43 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 530317...
Open
129,80 INR
High
134,00 INR
Low
129,40 INR
Mkt. cap
1,46 მლრდ.
Avg. vol.
15,26 ათ.
Volume
1,06 ათ.
P/E ratio
26,34
52-wk high
144,35 INR
52-wk low
69,70 INR
EPS
5,06 INR
Shares outstanding
7,53 მლნ.
No. of employees
112
Open
129,80 INR
High
134,00 INR
Low
129,40 INR
Mkt. cap
1,46 მლრდ.
Avg. vol.
15,26 ათ.
Volume
1,06 ათ.
P/E ratio
26,34
52-wk high
144,35 INR
52-wk low
69,70 INR
EPS
5,06 INR
Shares outstanding
7,53 მლნ.
No. of employees
112
News stories
From web sources and news partners
About Godavari Drugs Ltd
CEO-
Employees112
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
272,85 მლნ.
222,01 მლნ.
324,99 მლნ.
281,08 მლნ.
Cost of goods sold
201,10 მლნ.
148,82 მლნ.
261,64 მლნ.
198,04 მლნ.
Cost of revenue
201,10 მლნ.
148,82 მლნ.
261,64 მლნ.
198,04 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,43 მლნ.
15,77 მლნ.
15,07 მლნ.
14,77 მლნ.
Operating expense
51,45 მლნ.
54,37 მლნ.
40,29 მლნ.
62,30 მლნ.
Total operating expenses
252,55 მლნ.
203,19 მლნ.
301,93 მლნ.
260,35 მლნ.
Operating income
20,30 მლნ.
18,82 მლნ.
23,06 მლნ.
20,73 მლნ.
Other non operating income
-
-
6,44 მლნ.
-
EBT including unusual items
11,21 მლნ.
10,22 მლნ.
16,18 მლნ.
11,77 მლნ.
EBT excluding unusual items
11,21 მლნ.
7,70 მლნ.
15,14 მლნ.
11,77 მლნ.
Income tax expense
1,21 მლნ.
2,64 მლნ.
3,27 მლნ.
682,00 ათ.
Effective tax rate
10,76%
25,86%
20,20%
5,79%
Other operating expenses
30,98 მლნ.
32,49 მლნ.
19,10 მლნ.
41,61 მლნ.
Net income
10,01 მლნ.
7,58 მლნ.
12,91 მლნ.
11,09 მლნ.
Net profit margin
3,67%
3,41%
3,97%
3,95%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,61 მლნ.
-
Interest expense
-9,08 მლნ.
-11,11 მლნ.
-9,56 მლნ.
-8,96 მლნ.
Net interest expenses
-9,08 მლნ.
-11,11 მლნ.
-7,95 მლნ.
-8,96 მლნ.
Depreciation and amortization charges
6,04 მლნ.
6,12 მლნ.
6,12 მლნ.
5,93 მლნ.
EBITDA
26,34 მლნ.
24,94 მლნ.
29,15 მლნ.
26,81 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები